Emmaus Life Sciences to Present Additional New Data from its Phase 3 Sickle Cell Disease Trial at 57th Annual ASH MeetingDecember 02, 2015 Read More
Emmaus Life Sciences to Present at Maxim Group's Sickle Cell Disease Investor Conference on November 20November 20, 2015 Read More
